CLINICAL_TRIALS
trial_result
· 2009-12-29
Clinical Trial Update: Pharmacokinetic Study to Compare the Systemic Exposure of Differin® Gel, 0.3% or Differin® Gel, 0.1% [Phase 4]
Summary
Phase 4 pharmacokinetic study comparing systemic exposure of Differin Gel 0.3% vs 0.1% in acne vulgaris.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Galderma R&D | Conditions: Acne Vulgaris | Phase 4 | Status: COMPLETED | Results posted: 2009-12-29